Find Academic Supervisors

• Genomics
• Malaria Research
• Parasitology
• +3 more

David Serre is a Professor in the Department of Microbiology and Immunology at the University of Maryland School of Medicine, with an additional appointment at the Institute for Genome Sciences. His research focuses on developing genomic approaches to study eukaryotic pathogens, particularly Plasmodium vivax, the leading cause of malaria outside Africa. His laboratory investigates parasite responses to antimalarial drugs, host immune responses, and mosquito vector biology using genomic and transcriptomic techniques. Education 1997–2000: Engineering degree in Chemistry, École Nationale Supérieure de Chimie, Montpellier, France 2000–2004: PhD in Biology, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany 2004–2007: Postdoctoral fellowship, McGill University and Genome Quebec Innovation Centre, Montreal, Canada Research Focus Dr. Serre’s work integrates genomics to study Plasmodium vivax’s drug resistance, relapse mechanisms, and interactions with hosts and vectors. Key areas include: Genomic assays to characterize parasite drug responses Transcriptomic analysis of host immune responses Genomic studies of Anopheles mosquitoes as malaria vectors Recent Trends in Publications Recent work highlights genomic and transcriptomic approaches to dissect Plasmodium vivax biology, including: Single-cell RNA sequencing to resolve transcript isoforms and stage-specific expression Analysis of relapse dynamics and drug resistance mechanisms Microbiome studies in mosquitoes and environmental contexts Grants & Advising No explicit grants or advisee names are listed in the provided text. Collaborators include institutions like the Max Planck Institute, McGill University, and the Institute for Genome Sciences. Labs & Teams His lab is affiliated with the University of Maryland School of Medicine and the Institute for Genome Sciences, focusing on genomic and molecular approaches to infectious diseases.

• Microbiomics
• Genomics
• Complex Diseases
• +4 more

Elin Org is a Professor of Microbiomics at the University of Tartu's Institute of Genomics, where she also serves as Head of the Estonian Genome Centre and Vice Director of the Institute. Her academic career spans over two decades with significant contributions to microbiome and genomic research. Education: PhD in Genetics, University of Tartu (2006) Master's Degree in Molecular Biotechnology and Biomedicine, University of Tartu (2000) Bachelor's Degree, University of Tartu (1997) Classical Singing, Heino Eller Tartu Music School (1996) Professor Org's research primarily focuses on the intricate relationships between host and gut microbiota and their influence on metabolism and common complex diseases. Her work bridges microbiomics, genomics, and complex disease research, with particular emphasis on understanding how gut microbiome composition affects human health. She has pioneered research connecting long-term antibiotic usage with microbiota-dependent effects and has made significant contributions to understanding the role of gut microbiome in conditions such as gestational diabetes, endometriosis, and polycystic ovary syndrome. Her approach integrates advanced computational methods with comprehensive health data to uncover causal relationships in microbiome research. Her recent publications demonstrate a strong trend toward integrating microbiome data with extensive digital health metrics, using machine learning approaches to identify microbial predictors of health outcomes. This work is increasingly focused on translating microbiome research into clinical applications for disease prediction and personalized medicine approaches, particularly in the context of the Estonian Biobank initiative. Major Scientific Recognition: 2025 National Science Award in medical and health sciences 2023 and 2022: Recognized among the world's top 1% most cited researchers by Clarivate Analytics 2020: Member of AcademiaNet, a portal for top female researchers 2017: EMBO Installation grant 2013: Marie Curie International Outgoing Fellowship Professor Org has secured substantial research funding as principal investigator for multiple significant projects, including 'DISCERN - Discovering the causes of three poorly understood cancers in Europe' (€245,466, European Commission) and 'Improving colorectal cancer screening and prediction using microbiome-based biomarkers' (€760,450, Estonian Research Council). She has served as an opponent for numerous PhD theses across European institutions, contributing to the development of emerging researchers in her field. As Head of the Estonian Genome Centre, Professor Org leads a multidisciplinary research team that plays a crucial role in Estonia's transition from biobanking to personalized medicine applications. She is actively involved in international collaborations through COST networks including INFOGUT (focused on in vitro colon models) and ML4Microbiome (statistical and machine learning techniques in human microbiome studies), positioning her at the forefront of global microbiome research initiatives.

Mark EppingerView profile

Associate Professor

• Microbial Genomics
• Bioinformatics
• Infectious Diseases
• +5 more

Mark Eppinger, Ph.D., is an Associate Professor in the Department of Molecular Microbiology and Immunology at The University of Texas at San Antonio (UTSA), within the College of Sciences. His research is centered on microbial genomics and bioinformatics, with a focus on understanding infectious diseases caused by bacterial pathogens such as Yersinia pestis , Vibrio cholerae , and Escherichia coli O157:H7. Department: Molecular Microbiology and Immunology School: College of Sciences University: The University of Texas at San Antonio Email: Mark.Eppinger@utsa.edu Phone: 210-458-6276 Lab: BSE 3.404 Dr. Eppinger earned his Ph.D. in Microbial Genetics from the Max-Planck Institute for Developmental Biology and the University of Tübingen, Germany, and a B.S. in Biology from the same institution. Ph.D. in Microbial Genetics, Max-Planck Institute for Developmental Biology, University of Tübingen B.S. in Biology, University of Tübingen His research program applies microbial genomics and bioinformatics to investigate the evolutionary and ecological dynamics of bacterial pathogens. He focuses on phylogenomics, genome plasticity, virulence determinants, and host-pathogen interactions. His lab generates genomic data to understand how genetic variation influences transmissibility, infectivity, and disease outcomes in major public health threats. The available publications reflect a consistent focus on the genomics of foodborne and epidemic bacterial pathogens. Both book chapters deal with the genomic analysis of Escherichia coli and Yersinia , emphasizing evolutionary patterns, virulence mechanisms, and molecular epidemiology. These works highlight his expertise in integrating genomic data with public health applications. Dr. Eppinger has mentored a wide range of students, including doctoral candidates, postdoctoral researchers, master's students, and undergraduates. His lab has hosted international exchange students and Fulbright Fellows, indicating a collaborative and globally engaged research environment. He leads the Eppinger Lab at UTSA, which is part of the South Texas Center for Emerging Infectious Diseases (STCEID). The lab conducts cutting-edge genomic research on emerging pathogens and contributes to the development of diagnostic and therapeutic strategies to reduce human morbidity.

• Epidemiology of Birth Defects
• Gene-Environment Interactions in Perinatal Health
• Nutrition and Reproductive Outcomes
• +4 more

Gary M. Shaw is the Rosemarie Hess Professor and Professor (Research) at Stanford University , with courtesy appointments in the Department of Epidemiology and Population Health and Department of Obstetrics & Gynecology - Maternal Fetal Medicine . He serves as Co-PI of the March of Dimes Prematurity Research Center at Stanford and PI of the California Center for Finding Causes and Preventives of Birth Defects . His research focuses on the Epidemiology of birth defects Gene-environment interactions in perinatal outcomes Nutritional factors in reproductive health . He has developed machine learning approaches for precision parenteral nutrition and predictive models for preterm birth, while investigating persistent metabolomic signatures following hypertensive pregnancy disorders. Shaw's recent work explores Climate change impacts on reproductive health Maternal-fetal immune interactions Epigenetic mechanisms in perinatal disease with applications of multiomics to neonatal intensive care units. As a member of Bio-X and the Maternal & Child Health Research Institute , he contributes to translational research networks while serving as Associate Editor for Birth Defects Research and American Journal of Medical Genetics . He supervises Med Scholar Project student Richard Liang Doctoral co-advisor for Saskia Comess and Richard Liang Master's advisor for Lenae Joe while leading the Division of Neonatology as Associate Chair for Clinical Research (2012-2025). His laboratory work integrates Metabolomic profiling Proteomic analysis Computational modeling Machine learning for biomedical data to advance neonatal care through precision medicine approaches.

Aleksandr AravkinView profile

Associate Professor

• Optimization
• Machine Learning
• Data Science
• +4 more

Aleksandr (Sasha) Aravkin is Associate Professor in the Department of Applied Mathematics and Adjunct Associate Professor of Health Metrics Sciences, Mathematics, and Statistics at the University of Washington. He serves as Director of Mathematical Sciences at the Institute for Health Metrics and Evaluation (IHME), where he leads the Mathematical Sciences and Computational Algorithms team and contributes to strategic direction for applying mathematical sciences to analytic challenges. Dr. Aravkin earned his PhD in Mathematics (Optimization) and MS in Statistics from the University of Washington in 2010, following a BSc in Mathematics and Computer Science in 2004. His educational background forms the foundation for his interdisciplinary research approach. His research expertise spans large scale optimization, machine learning, data science, convex and variational analysis, algorithm design, robust statistics, inverse problems, and uncertainty quantification . These methodologies are applied across diverse domains including health metrics, computational medicine, tracking and navigation, seismic imaging, computational finance, and neuroscience. Dr. Aravkin has pioneered approaches for fusing physics-based and data-driven models, enabling innovative solutions to complex problems. Dr. Aravkin's publication record demonstrates a strong focus on health metrics and Global Burden of Disease studies, with recent work emphasizing meta-analytic approaches for risk-outcome relationships. His research spans epidemiological modeling, health effects of various exposures, and forecasting disease burden across populations. The publications reveal a consistent pattern of high-impact work in top journals including The Lancet and Nature Medicine, often addressing critical public health questions through rigorous statistical and mathematical frameworks. At IHME, Dr. Aravkin has led significant projects including the Burden of Proof Studies (2019-2024) which analyzed 153 risk-outcome pairs, and COVID-19 Modeling (2020-2023) where his team developed forecasting models and excess mortality estimation methods. He has also been instrumental in developing the Evidence Score model, requiring novel algorithmic approaches. His work bridges theoretical mathematical sciences with practical applications to improve global health policy and practice.

Mandi de MestreView profile

Professor

• Reproductive Biology
• Placental Development
• Equine Medicine
• +5 more

Dr. Mandi de Mestre is a Professor in the Department of Biomedical Sciences at Cornell University's College of Veterinary Medicine. As Director of the Baker Institute for Animal Health and holder of the Dorothy Havemeyer McConville Professorship of Equine Medicine, her research focuses on equine pregnancy biology, placental development, and fetal health. Director, Baker Institute for Animal Health Dorothy Havemeyer McConville Professor of Equine Medicine Affiliated with Cornell's College of Veterinary Medicine Her laboratory investigates: Molecular mechanisms of placental development Genetic causes of early pregnancy loss Congenital musculoskeletal disorders in Thoroughbreds Non-invasive diagnostics for fetal health Comparative studies linking equine and human pregnancy pathologies Recent research trends show strong emphasis on genomic stability, immune interactions during implantation, and epidemiological factors affecting equine pregnancies. Collaborations with institutions like the University of Nottingham and Royal Veterinary College UK highlight her interdisciplinary approach. The Equine Pregnancy Laboratory employs molecular biology, immunology, and genetics to address critical gaps in placental biology, with implications for both veterinary and human medicine.

• Neurosciences
• Physiology
• Microbiology
• +5 more

Professor Elisa Hill is a distinguished academic at RMIT University where she serves as a Professor in the Department of Health and Biomedical Sciences within the College of Science. She leads the Gut-Brain Axis Laboratory and holds the significant position of Deputy Chair of the Academic Board at RMIT University. Her career spans prestigious institutions including The University of Melbourne and research collaborations in Paris, France. Professor Hill earned her PhD in Neuroscience from The University of Melbourne in 2002. She subsequently undertook a CNRS postdoctoral position in Paris studying cortical neuronal diversity. Returning to Melbourne in 2006 as an NHMRC Howard Florey Centenary Fellow, she joined Prof Steve Petrou's laboratory to investigate neuronal networks in genetic mouse models of epilepsy. In 2009, she imported the Neuroligin-3R451C mouse model of autism to Australia, establishing herself as a pioneer in gut-brain axis research. Her research program focuses on three interconnected areas: identifying causes of gut dysfunction in transgenic mouse models of neurological disease, determining how neurons communicate with the lymphoid system and inflammation, and understanding interactions between the nervous system and bacteria. Professor Hill has demonstrated that gene variations associated with autism alter neuron populations in the mouse enteric nervous system, affecting gut motility, permeability, microbiome composition, and behavior. Her laboratory has developed sophisticated capabilities including video-imaging assays for gut motility, immunofluorescence for neuronal and immune cell analysis, and whole-cell patch clamp electrophysiology for neuronal activity profiling. Analysis of her recent publications reveals a strong focus on the gut-brain axis in autism, with particular attention to the Neuroligin-3R451C mouse model. Her work spans neuroimmunology, gastrointestinal physiology, microbiome interactions, and behavioral neuroscience, demonstrating an increasingly interdisciplinary approach that integrates molecular, cellular, and systems-level perspectives. A notable trend is the expansion of her research into translational applications, including biomaterial development for urogynaecological health. NHMMRC Howard Florey Centenary Fellowship ARC Future Fellowship RMIT Senior Vice Chancellor's Research Fellowship Professor Hill actively supervises numerous PhD students including Vic Lin, Yuansong Li, and Mohammed Al Alamoudi, among others. Her research has been supported by major funding bodies including NHMRC, US Department of Defense CDMRP, CNRS, ARC, and RMIT. She leads the Gut-Brain Axis Laboratory, which collaborates extensively with researchers across institutions, particularly with Prof Ashley Franks at La Trobe University. The laboratory employs a multidisciplinary team with expertise in neuroscience, microbiology, immunology, and gastrointestinal physiology, utilizing advanced techniques to investigate the complex interactions between the nervous system, immune system, and gut microbiome.

Noa Pinter-WollmanView profile

Professor

• Collective animal behavior
• Social network analysis
• Behavioral ecology
• +3 more

Noa Pinter-Wollman is a Professor in the Department of Ecology and Evolutionary Biology at the University of California, Los Angeles, within the College of Life Sciences . Her work integrates field experiments, laboratory assays, computational modeling, and social network analysis to understand how individual variation among animals translates into emergent collective behavior, and how these dynamics intersect with conservation challenges. Research Focus: Mechanisms underlying collective decision-making in social insects (especially Argentine ants and harvester ants) Social network structure and its ecological consequences in endangered griffon vultures Interface between spatial ecology and social behavior, including impacts on disease transmission and conservation management Biomimetic insights from social animals to inform resilient human-designed systems Across 2023–2025, her team has produced a steady stream of high-impact articles that collectively advance four thematic pillars: (1) microbiome–behavior feedbacks in ants, (2) conservation technology for scavengers, (3) network-analytic methods for disentangling spatial versus social drivers of interaction, and (4) cooperative strategies that underlie invasion success in ants. The work is notable for integrating high-resolution tracking technologies with rigorous statistical modeling. Funding & Collaborations: Current NSF awards include the collaborative grant “ The causes and consequences of Higher Order Interactions (HOI) ” and prior support for “ Uncovering how links between social and spatial interactions affect ecological processes .” These grants foster interdisciplinary partnerships spanning ecology, computer science, and conservation practice. Laboratory & Team: The Pinter-Wollman Lab at UCLA houses graduate researchers, post-docs, and undergraduates who conduct integrative studies on ants, paper wasps, spiders, and vultures. The lab website ( https://pinter-wollmanlab.weebly.com ) provides protocols, data resources, and outreach materials that translate basic findings into actionable conservation guidance for wildlife managers.

Pier PalamaraView profile

Associate Professor

• Statistical Genetics
• Population Genetics
• Genomics
• +6 more

Pier Palamara is an Associate Professor of Statistical and Population Genetics at the University of Oxford's Department of Statistics, affiliated with the Centre for Human Genetics. He holds a PhD in Computer Science from Columbia University (2014) and completed postdoctoral training at Harvard Chan School of Public Health and the Broad Institute of MIT and Harvard. His research integrates statistics, computer science, and genetics to develop methods for analyzing large genomic datasets, focusing on evolutionary parameters, demographic history, complex trait genetics, and disease variation. Key research interests include reconstructing population movements via genetic data, studying natural selection and mutation rates in human genomes, and developing scalable algorithms for genomic analysis. He leads the Palamara Lab, which collaborates on projects like the Genomics England haplotype reference panel and the UK Biobank imputation. His lab's work is supported by grants and partnerships, and they develop software tools such as ASMC, Quickdraws, and Threads. Recent publications highlight contributions to Indo-European genetic origins, scalable mixed-model association methods, and ancient DNA analysis of European farmers. He advises graduate students and has mentored researchers in computational biology and statistical genetics.

Lucy GloverView profile

Researcher

• Molecular Parasitology
• DNA Repair
• Antigenic Variation
• +7 more

Lucy Glover is a Researcher and Group Leader of the Trypanosome Molecular Biology laboratory at the Department of Parasites and Insect Vectors, Institut Pasteur, Paris, France. She joined the institute in March 2016 as a G5 group leader, focusing on the molecular mechanisms of antigenic variation and DNA repair in Trypanosoma brucei , the causative agent of Human African Trypanosomiasis. Her research integrates molecular, biochemical, and high-throughput approaches to study DNA recombination and immune evasion. Institut Pasteur, Paris (2016–Present) PhD, London School of Hygiene and Tropical Medicine Her research interests center on antigenic variation , DNA repair , and homologous recombination in trypanosomes. She investigates how DNA double-strand breaks influence variant surface glycoprotein (VSG) switching, a critical process for parasite survival in the host. Her lab uses advanced techniques such as RIT-seq, phosphoproteomics, and CRISPR-based tools to dissect these mechanisms at the molecular level. The recent publications of Lucy Glover span molecular parasitology, DNA damage response, and diagnostic development. Key themes include the role of the MRN complex in DNA repair, phosphoproteomic profiling of DNA damage responses, and the design of CRISPR-based diagnostics for HAT. Her work reveals how chromosomal context influences repair pathways and antigenic variation, contributing to a deeper understanding of parasite biology. While no formal scientific awards are listed in the provided text, her contributions are evident through high-impact publications and leadership in collaborative research projects. Lucy Glover advises several PhD and postdoctoral researchers, including Emilia MacLaughlin, Nuria Sima Teruel, and Alix Thivolle. Her lab is supported by institutional initiatives such as LabEx IBEID and transversal drug discovery programs. She collaborates with teams working on host-pathogen interactions, genomics, and infectious disease epidemiology. Her laboratory is part of the Department of Parasites and Insect Vectors and participates in departmental retreats and seminars. The team includes post-docs, research engineers, and administrative staff, reflecting a collaborative and interdisciplinary research environment focused on combating neglected tropical diseases.

Wendy JohnsonView profile

Professor

• Individual Differences
• Intelligence
• Personality Development
• +3 more

Wendy Johnson is a Professor of Psychology at the School of Philosophy, Psychology and Language Sciences, University of Edinburgh. She holds a Personal Chair of Differential Development and is currently on research leave from July 2019 to December 2020. Her research focuses on individual differences in intelligence and personality, lifespan development, genetic and environmental influences on behavior, and aging. She has led multiple research grants, including projects on gene-environment interplay in aging outcomes, social causes of life chances, and the longitudinal study of cognitive function in the Scotland in Miniature cohort. Her current PhD students include Alicia Aranda Diaz, Emma Waterston, Alicia Forsberg, and Ross Stewart. Key research areas include personality stability and change, the role of environmental factors in cognitive aging, and interactions between genetics and social contexts. She has contributed to over 200 research outputs, with recent work exploring bidirectional associations between loneliness and health, and the replicability of personality-trait life outcomes across cultures. Grants leadership includes principal investigator roles in projects funded by MRC, EU, and non-EU grants totaling over £multi-million. Her work bridges behavioral genetics, developmental psychology, and public health, emphasizing the interplay of biological and social factors in human development.

• Ecology
• Evolutionary Biology
• Behavioral Ecology
• +5 more

Meinolf Ottensmann is a Researcher at Bielefeld University affiliated with the Faculty of Biology / Behavioral Science . He contributes to the Transregio 212 NC³ collaborative research project focused on individualization across behavior, ecology, and evolution. His research spans interdisciplinary topics in: Avian parasite-host interactions Microbiome dynamics in wild vertebrates Physiological costs of infection Spatial ecology of raptors Evolutionary immunogenetics Recent publications demonstrate methodological innovation in ecological analysis through: Development of the GCalignR package for gas-chromatography data alignment Standardized mortality cause frameworks for GPS-tagged birds Statistical approaches to territorial behavior analysis Research trends show particular focus on: Common buzzard ( Buteo buteo ) as model organism Leucocytozoon blood parasites MHC diversity in wild populations Climate change impacts on juvenile raptor survival

Rob HegeleView profile

Professor

• Genetics
• Endocrinology
• Dyslipidemia
• +5 more

Rob Hegele is a Distinguished University Professor at Western University, holding appointments in the Department of Medicine (Division of Endocrinology) and Biochemistry. He serves as a Scientist in Molecular Medicine at Robarts Research Institute and is the Director of the London Regional Genomics Centre. Dr. Hegele also holds two prestigious research chairs: the Jacob J. Wolfe Distinguished Medical Research Chair in Human Gene Function and the Martha G. Blackburn Chair in Cardiovascular Research. Dr. Hegele's research focuses on the genetic basis of human disorders, particularly dyslipidemia (including high cholesterol and high triglycerides) and type 2 diabetes. With over 815 publications cited more than 60,000 times, he is recognized as one of the world's top 1% highly cited scientists. In 2021, Expertscape.com ranked him #1 globally in hypertriglyceridemia and #2 for disorders of lipid metabolism. His work bridges basic science and clinical practice, as evidenced by his care for over 2,400 patients in his lipid clinic at University Hospital and his involvement in pioneering new treatments. Analysis of Dr. Hegele's recent publications reveals a strong emphasis on clinical guidelines, genetic mechanisms of lipid disorders, and novel therapeutic approaches. His work spans from fundamental genetic discoveries to practical clinical applications, with particular focus on familial hypercholesterolemia, remnant cholesterol, and emerging treatments like gene silencing therapies for severe dyslipidemias. The publications demonstrate his leadership in developing consensus statements that shape global clinical practice. Young Investigator Award, American Federation for Clinical Research (1995) Canada Research Chair in Human Genetics, Tier I (2000) Elected to Membership, American Society for Clinical Investigation (2001) American Heart Association Top Ten Scientific Discoveries (2001) Government of Ontario Distinguished Researcher Award (2001) Canadian Diabetes Association Young Scientist Award (2002) Distinguished University Professor Award, UWO (2007) Elected to Fellowship, Canadian Academy of Health Sciences (2007) American Heart Association George Lyman Duff Memorial Lecture Award in Atherosclerosis Research (2019) Canadian Society of Clinical Chemists Award for Research Excellence (2020) Dr. Hegele has made significant contributions to medical education and clinical practice, having trained numerous physicians, medical students, and graduate students. He has co-authored many clinical practice guidelines for cholesterol, blood pressure, and diabetes, and has contributed to international guidelines on familial hypercholesterolemia and hypertriglyceridemia. His laboratory has discovered the molecular genetic basis of 25 human diseases. Dr. Hegele's work exemplifies the translation of basic genetic discoveries into clinical applications that improve patient care.

• Malaria
• Plasmodium falciparum
• Population Genetics
• +7 more

Dr. Amy Bei is an Associate Professor of Epidemiology (Microbial Diseases) at the Yale School of Public Health , with affiliations to the Yale Institute for Global Health . Her research spans multiple continents with ongoing projects in Senegal and collaborations across Sub-Saharan Africa. Yale School of Public Health Department of Epidemiology of Microbial Diseases Yale Institute for Global Health Research Focus : Dr. Bei's work intersects population genetics, genomics, molecular genetics, epidemiology, and immunology in the context of Plasmodium – the causative agent of malaria. She applies translational systems biology to understand how antigenic diversity affects immune evasion, transmission, and virulence in areas with declining malaria transmission. Her team studies genotype-specific immunity, transmission potential in mosquito vectors, and malaria vaccine candidate discovery and validation. Publications demonstrate sustained work in genomic surveillance, drug resistance monitoring, vaccine development, vector biology, and field-applicable method development across multiple countries including Senegal, Uganda, and the Greater New Haven area. Her work includes collaborations with multiple Yale departments and international institutions in West and East Africa. Key Collaborations: Harvard T.H. Chan School of Public Health Institut Pasteur de Dakar University of Cheikh Anta Diop Yale School of Medicine African Centers of Excellence

• Renal Medicine
• Chronic Kidney Disease (CKD)
• Cardiovascular Complications in CKD
• +4 more

Dr. Kaitlin Mayne is a Clinical Lecturer in Renal Medicine at the School of Cardiovascular & Metabolic Health, University of Glasgow. Her research focuses on chronic kidney disease (CKD), cardiovascular complications, and the effects of pharmacological agents like empagliflozin and vicadrostat. She leads analyses in major trials such as EMPA-KIDNEY and EASi-KIDNEY, exploring drug efficacy in CKD populations. Her work spans fluid management, biomarker discovery, and guideline-informed clinical practices. Notably, she investigates post-COVID-19 multisystem syndromes and socioeconomic disparities in healthcare outcomes. Dr. Mayne collaborates widely, contributing to high-impact journals in nephrology and cardiology. Research interests include SGLT2 inhibitors’ role in CKD progression, bioimpedance technologies, and frailty in renal patients. Her recent studies highlight empagliflozin’s benefits in reducing uric acid levels and cardiovascular risks, alongside exploring aldosterone synthase inhibitors for cardio-renal protection. She also examines sex/gender differences in CKD management and hemodialysis outcomes through inflammatory biomarkers. In 2025–2023, her articles emphasize drug mechanisms, subgroup analyses (e.g., Japanese CKD patients), and long-term trial results. Collaborations with groups like the EMPA-KIDNEY Collaborative Group underscore her role in large-scale clinical research. While no awards are listed, her prolific peer-reviewed output reflects her academic standing. Dr. Mayne’s advising and grants are not detailed here, but her publications suggest involvement in collaborative grants supporting CKD and post-COVID research. She contributes to interdisciplinary teams, such as those investigating renal MRI advancements and post-infectious illness trajectories.